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Abstract
All multicellular organisms live in a strong bond with the microorganisms from around 
the world, and the humans are not the exceptions. Human microbiota (a complex bacte-
rial community) contains about 1014 microbial cells, 10 times more than the content of 
the cells from our body and the microbial genome named microbiome, 1000 more that 
the human genome. It colonises any surface of the human body, above our skin, in the 
genitourinary tract, gut and airways. From all this, the gut is the most colonised organ, 
with an amount of almost 70% of the human microbes. Considering the large size of the 
gut, compared with a tennis terrain, filled with substances that plays a key, nutritive role 
for the microbes, polyphenols are micronutrients from our diet, with an emerging role in 
the modulation of the colonic microbial population composition and activity. Therefore, 
many studies underline that long-term consumption of diets rich in plants polyphenols 
offers protection against cancer, cardiovascular diseases, diabetes, osteoporosis and neu-
rodegenerative diseases. This chapter reviews the biological effects of plant polyphenols 
in the context of relevance to human health, especially considering the food functional-
ity area, together with the complexity of the human microbiota and the bioavailability 
highly dependent on their intestinal absorption.
Keywords: dietary polyphenols, microbiota, microbial metabolism, human health, 
interactions
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1. Introduction
Phytochemicals are the richest resources for human consumption because of their various 
applications. By using phytochemicals, new and novel products for the treatment and preven-
tion of serious diseases could be improved.
Bioactive plant secondary metabolites play a crucial role in plant growth, development and 
physiology. The effective components of medicinal plants are usually the secondary metabo-
lites, and the synthesis of them is affected by a variety of factors, such as biotic and abiotic 
effectors. Also, secondary metabolites help plants to survive, defence and compete with oth-
ers. Thus, the production of the majority of plant phenolic compounds could be induced by 
the applications of abiotic and biotic elicitors. Due to this knowledge, the usage of elicitors is 
usually preferred to the optimisation of rare phytochemical sources.
Polyphenols are secondary metabolites from plants, characterised by two aromatic rings, tai-
lored by hydroxylated phenyl moieties, in large amounts in fruits, vegetables, cereals and 
beverages. The compounds are showing a large diversity, including chlorogenic acids, tan-
nins and flavonoids (flavonols, flavanones, flavan-3-ols, anthocyanins, isoflavones and fla-
vones). Dietary polyphenols are substrates for gut and colonic microbiota. They and their 
metabolite allow the maintenance of gastrointestinal health, interacting with epithelial cells 
and modulating the microbial complexity of the gut. Polyphenolic compounds play the role 
of promoting factors of growth, proliferation or survival for beneficial gut microbiota, exert-
ing beneficial prebiotic activity and inhibiting the proliferation of some pathogenic bacteria 
(Salmonella, Helicobacter). Although in the raw material, phenolic compounds occur as glyco-
sylated derivatives, in order to exert their pharmacological effect, these polyphenols undergo 
various intestinal transformations, allowing the digestive enzymes and also the microbiota 
metabolism to eliminate the sugar component or other hydroxyl moieties and to release the 
aglycons that are further absorbed into the blood circulation, and from there, they became 
relevant for the organs, exhibiting strong biological effect.
2. Polyphenols, gut microbiota and health
The intestinal tract is colonised with a whole bacterial community (microbiota) that has more 
than 800 different bacterial species [1]. They exert a metabolic effect, due especially to the 
dietary compounds that provide energy, a supply of nutrients for the organism and transfor-
mations of xenobiotics. A normal composition for the gut microbiota implies a good life for 
the host, while imbalances are tightly associated with metabolic disorders. The factors that 
influence the gut microbiota are environmental (diet, the intake of antibiotic and xenobiotic) 
and endogenous (the adult-type microbiota is different from the child-type microbiota).
It develops a large number of functions—protective, immune and metabolic—correlated with 
the health status of the host. The intestinal microbiota is essential for the postnatal develop-
ment that is for the content of T cells, intraepithelial T cells and immunoglobulins [2]. It is 
well known that prebiotics and prebiotic-like phytonutrients may exert a beneficial growth 
activity of bacteria and inhibit pathogenic bacteria, as a target for the biological compounds 
orally administered. It is also to mention the genes involved in the utilisation of the carbo-
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hydrates and lipids (the microbiome), allowing the enzymes to utilise carbohydrates, host-
derived glucuronides (like mucin), deconjugate and dehydroxylate the bile acids, reduce the 
cholesterol, synthesise some vitamins (K and B groups) and also participate to the amino 
acids and xenobiotic metabolism.
The gut colonisation starts immediately after birth, being dominated by Bifidobacterium 
population, due to the breast feeding, and stabilises for the first 12 months. Analyses show 
that adults and weaned children have Bacteroides population in their microbiota, followed 
by Firmicutes, like Eubacterium, Ruminococcus, Clostridium and Bifidobacterium. In infants, 
Escherichia coli, Raoultella and Klebsiella form the bacterial complex, dynamic and susceptible 
to changes, made by dietary factors and other diverse disorders [3].
It is to underline that two categories of enzymes are exerting an important activity of degrad-
ing the polysaccharides and xenobiotics: β-glycosidases and β-glucuronidases, which may 
act a beneficial or harmful role. β-Glycosidases are involved in the nutrient utilisation, which 
lead to body energy, by fermentation of dietary polysaccharides, thus resulting mainly short-
chain fatty acids, with different functions (acetate and propionate access the portal circulation 
and impact the lipid metabolism, butyrate is used by enterocytes and positively influence 
the cell growth and differentiation). Unlike the β-glycosidases, β-glucuronidases release the 
toxins and another endogenous particle that have been glucuronide in the liver and excreted 
with the bile into the gut. Studies performed on about 40 bacterial strains, dominant in 
human faeces, showed a low β-glucosidase activity for Gram-positive Firmicutes, while the 
β-glucuronidase activity is noted for some Firmicutes, with clostridial cluster [4].
Intestinal enzymes are also related to the cholesterol and bile acid metabolism. Following this 
pathway, cholesterol is degraded to coprostanol, and bile acids are converted into second-
ary bile acids through deconjugation and dehydroxylation (deoxycholic acid and lithocholic 
acid). For the obtaining of this metabolites, incriminated for their carcinogenetic role, are pri-
mary mentioned Bacteroides intestinalis and secondarily Bacteroides fragilis and Escherichia coli.
Also, colonic strains are involved actively in the protein synthesis, highlighting the source of 
amino acids for the human organism. At least 1–20% of circulating lysine and threonine in 
adults are derived from intestinal microbiota [5].
The colonisation of germ-free mice reduces the levels of circulating fasting-induced adipose 
factor (Fiaf) and the skeletal muscle and liver levels of phosphorylated AMP-activated protein 
kinase, contributing to fat storage [6].
There can be described a straight correlation between the polyunsaturated fatty acids and 
gut microbiota. In vitro studies performed with Lactobacillus strains (L. rhamnosus, L. casei, L. 
delbrueckii subsp. bulgaricus) have shown that different concentrations of these acids (10–40 
μg/mL) inhibited growth and adhesion to mucus of all tested strains, while low concentration 
of gamma-linoleic and arachidonic acid (5 μg/mL) exerted a positive effect on the growth and 
mucus adhesion of L. casei [7]. Fatty acids affect the sites for the gastrointestinal microbiota, 
modifying their composition in the intestinal wall. In clinical trials, atopic eczema children diet 
supplemented with formulation containing Bifidobacterium Bb-12 or Lactobacillus GG exerted 
different effects on plasma lipids; the first one increased the level of alpha-linoleic acid, sug-
gesting that interactions between prebiotics and dietary polyunsaturated fatty acids could be 
established, although further studies in vivo are needed to confirm this hypothesis [8].
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Briefly, plant polyphenols have a bioavailability and exert their beneficial effects depending 
on their transformation by gut microbiota, taking into account the polyphenol type and iden-
tifying the responsible microorganism.
It is well known that dietary polyphenols and their metabolites contribute to the health by 
modulating the gut microbiota, stimulating the beneficial bacteria and inhibiting the patho-
gens ones, exerting prebiotic-like effects [9].
3. Microbial metabolism of polyphenols
We can distinguish among polyphenols flavonoids and nonflavonoids (Figure 1).
Flavonoids are classified into further classes according to their chemical structure: flavanones, flavones, 
dihydroflavonols, flavonols, flavan-3-ols, anthocyanidins, isoflavones and proanthocyanidins [11].
Non-flavonoids can be divided into simple phenols, phenolic acids, benzoic aldehydes, hydro-
lysable tannins, acetophenones and phenyl acetic acids, hydroxycinnamic acids, coumarins, 
benzophenones, xanthones, stilbenes, lignans and secoiridoids. They can be found in foods 
and are important to human health. Among these, resveratrol is unique in the grapes and 
red wine; ellagic acid is found in berry fruits (strawberries and raspberries) and in the skins 
of different tree nuts. Lignans can be found in flax, sesame and many grains. Curcumin is a 
strong antioxidant from turmeric. Rosmarinic acid is a dimer of caffeic acid and ellagic acid is 
a dimer of gallic acid. While gallic acid and ellagic acid are found in the free form, their glu-
cose esters, known as hydrolysable tannins, also exist in plants. The C6-C3 hydroxycinnamate 
derivatives occur mainly as conjugates with tartaric acid or quinic acid and can be found as 
 Figure 1. Phenolic compounds encountered in food [10].
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chlorogenic acids. These last compounds, principally 3-O-, 4-O- and 5-O-caffeoylquinic acids, 
form 10% of green coffee beans (Coffea canephora). Regular consumers of coffee may provide 
a daily intake in excess of 1 g of chlorogenic acids, and these may conclude the major diet.
Usually, they are metabolic products of chloroplasts, as defence against oxidative damage 
during photosynthesis [12], but can also be produced by sexual organs as defence against 
solar UV, at the root level or as defence against virus, bacteria and fungi [13].
After ingestion, depending on their chemical composition, phenolic compounds are absorbed 
in the small intestine or, in some cases, can be found in the unchanged form in the colon. Only 
a small percentage (5–10%) of the total polyphenol intake is absorbed in the small intestine. 
The remaining polyphenols (90–95%) accumulate in the intestinal lumen and, following the 
bile pathway, represent the target for the gut complex, subject for the enzymatic activity.
Bacteria is well represented in the colon, where around 300–500 different species live. The 
most common bacteria are Bacteroides, in an amount of 30% of all gut, followed by Clostridium, 
Prevotella, Eubacterium, Ruminococcus, Fusobacterium, Peptococcus and Bifidobacterium. The lowest 
concentrations are described for E. coli and Lactobacillus. There is a direct established correlation 
between the levels of Prevotella and a children high-fibre diet. Also, there are data that confirm 
the same higher levels of Prevotella in diets’ full field with polysaccharide foods, in contrast with 
a long-term diet rich in saturated fat, in which the microbiota is represented by Bacteroides strains 
[14]. The colonic pH (especially the decrease from 6.5–5.5) plays an important role, with the ten-
dency to suppress Bacteroides spp. and promotes butyrate-producing Gram-positive bacteria 
[15]. After absorption into the small intestine, the phenolic compounds are involved into Phase I 
reaction (oxidation, reduction and hydrolysis) or, particularly, Phase II biotransformation (con-
jugation) in the enterocytes and hepatocytes, thus resulting water-soluble metabolites (methyl, 
glucuronide and sulphate derivatives), released into the blood circulation in order to achieve the 
organs where the effect is developed or excreted into the urine. But, since all human hosts have 
their own unique signature of the intestinal complex of bacteria, like the fingerprint, human 
intestinal microbiota composition can modulate the polyphenol impact on health (Figure 2).
 Figure 2. Routes for dietary polyphenols and their metabolites in humans.
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4. Influence of phenolic compounds in gut microbiota composition
The level of biotransformation complies with two factors: the chemical structure of the poly-
phenol, related to the metabolite that can be absorbed and the properties that can generate a 
beneficial effect, and the composition of gut microbiota, because specific biotransformation 
requires particular species or strains with special genes for specific enzymes (Figure 3).
4.1. Flavonoids
4.1.1. Flavanones and flavonols
The most common flavanones are: hesperitin, naringenin, naringin, hesperidin, abundant in 
citrus fruits and tomatoes. Well-known flavonols are quercetin and rutin, found as glycosyl-
ate derivatives in onions, capers, apples, broccoli, grapefruit and plums. The position of the 
hydroxyl group may influence the degradation of the compound, related with the glycosidic 
bond (C- or O-glycoside) and the degradation rates, which seems to be much slower for the 
C-glycosidic metabolism than for the hydrolysis of the O-glycosidic bond (Figure 4). From 
this point of view, the slow-degrading compound will be more bioavailable, because they can 
be greater absorbed than the ones that are quicker degraded in the colon.
In different studies involving six bacterial strains (Bacteroides galacturonicus, Lactobacillus sp., 
Enterococcus caccae, Bifidobacterium catenulatum, Ruminococcus gnavus and E. coli), different con-
centrations exerted an inhibitory effect on the growth of all analysed bacterial species. For 
hesperetin, the effect was weaker. This fact was explained by the dependency of the potential 
of these compounds on the sugar presence/absence in the moiety [16].
 Figure 3. Biosynthesis of the flavonoid families [12].
Phenolic Compounds - Biological Activity30
In the presence of different flavonols (galangin, kaempferol, fisetin, quercetin), Bifidobacterium 
adolescentis is conducted to an anti-inflammatory effect, in the presence of nitric oxide, to 
which fisetin was the first responsive, by decreasing the nitric oxide with 76% [17].
Another study that underlines the viability of four bacterial strains (E. coli, Staphylococcus 
aureus, Salmonella typhimurium and L. rhamnosus) was tested among pure polyphenols, in a 
range of concentrations between 62.5 and 1000 μg/mL. All tested flavanols decreased the bac-
terial growth but especially quercetin and naringenin, with the lowest minimum inhibitory 
concentration (MIC) values. S. aureus was the most sensitive, while L. rhamnosus required a 
MIC of 125 μg/mL [18].
Following their bioavailability, flavonols and flavanones are antiviral, in vitro assays per-
formed with quercetin showed an increased bacterial cell membrane, diminishing cell motility, 
an important factor of the bacterial virulence [12]. From literature data results, quercetol and 
its heteroside (rutoside) have the greatest therapeutic potential. From this point of view, fla-
vones, especially quercetol, are evaluated for their antioxidant capacity correlated to their use 
in treatment of different diseases induced by reactive oxygen species (ROS) liberation. These 
substances act at cellular membrane level (reduce lipid per oxidation and increase membrane 
resistance) and endoplasmic reticule.
Antioxidative capacity of flavones from selective dried extracts can be determined in aqueous 
as well as in different concentrations of alcoholic solutions.
The methods used for antioxidant capacity assessment are based upon antioxidants’ possibil-
ity to annihilate free radicals action by hydrogen atom transfer (HAT) method or an electron 
 Figure 4. Molecular structure of Citrus flavonoids [12].
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transfer single electron transfer (SET). Using these methods they can reduce different oxi-
dant substances. HAT methods are solvent type and pH range independent and most rapid 
than SET methods. The most cited methods for antioxidant capacity determination are ferric 
reducing antioxidant power (FRAP) (from SET methods) and trolox equivalent antioxidant 
capacity (TEAC) (from SET and HAT methods).
Previously conducted researches on mice poisoned with lead acetate and treated with querce-
tol revealed quercetol role in lowering enzymatic activity of superoxide dismutase (SOD), cat-
alase, demonstrating indirect action as possible antidote (ratio of lead acetate bioinactivation/
quercetol = 2.18).
4.1.2. Flavanols
(−) Epicatechin and (+) catechin, flavanol monomers, in a range of concentrations of 150–1000 
mg/mL promoted the growth of Eubacterium rectale, Clostridium coccoides, the lowest concen-
tration being registered for Lactobacillus spp. and Bifidobacterium spp. [19].
The characteristic carbonyl group lacks from the structure of flavan-3-ols aglycones, at C4 (as 
found in flavonols and flavanones). This may be the reason to understand its transformation 
by colonic microbiota which modifies other types of flavonoids, as Eubacterium ramulus.
Once the initial gallate esters have been metabolised, the aglycones give rise to diphenylpropan-
2-diol through a C-ring opening, which is further converted into 5-(3′, 4′-dihydroxyphenyl)-γ-
valerolactone. This lactone ring opens and gives rise to 5-(3, 4-dihydroxyphenyl)valeric acid. 
Further transformations generate OH-phenylpropionic and hydroxy-benzoic acids (Figure 5) [2].
Several studies are focused on the main catechin of green tea leaves, epigallocatechin-3-gallate, 
that have been reported for the anti-infective properties. The inhibition effects refer to hepatitis 
 Figure 5. Colonic degradation of epicatechin tannins.
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C virus, HIV-1, influenza virus, adenovirus, Epstein-Barr virus and herpes simplex virus. The 
mechanism involved is related to the attachment of virions to cells downregulating CD4 cell sur-
face receptor expression; the inhibition of the proviral genome at the time of integrating into the 
host cell, by binding between the integrase and the viral DNA; also the inhibition of endosomes 
and lysosomes required for the fusion of viral and cellular membranes; and the inhibition of 
muraminidase activity responsible for preventing self-aggregation of virus particles [12].
It is to underline that epigallocatechin-3-gallate inhibits epimastigotes’ growth of Trypanosoma 
cruzi and the binding of Plasmodium falciparum to the ICAM-1 cellular receptor, related to 
malaria. The lethal mitochondrial damage above Leishmania donovani and Leishmania amazo-
nensis has been explained by the inhibition of the parasite arginases.
In vitro studies, the main tea phenolic aglycones (3-O-methylgallic acid, gallic acid and caf-
feic acid), on pathogenic intestinal bacteria inhibited the growth of Clostridium perfringens, 
Clostridium difficile and Bacteroides subspp. Caffeic acid exerted a strong inhibiting effect above 
E. coli, Salmonella, Pseudomonas, Clostridium and Bacteroides.
4.1.3. Isoflavones
Most of the studies performed on isoflavones showed an important effect in the postmeno-
pausal period. Greater concentrations of isoflavones are found in plants from the Fabaceae 
family (soy, lentils, beans, chickpeas).
All isoflavones (daidzein, genistein, formononetin) are glycosylated and therefore are not 
absorbed across enterocytes, because they have great polarity and molecular weight. Their 
bioavailability implies the conversion of glycosides into bioactive aglycones, following the 
pathway of β-glucosidases from the small intestine (Lactobacillus, Bifidobacterium). The most 
important isoflavone, daidzein, is metabolised depending on the gut microbiota. Some indi-
viduals produce (s)-equol through dihydrodaidzein and tetrahydrodaidzein, and other pro-
duce O-desmethylangolensin, generated by Clostridium sp. We can distinguish two types of 
individuals: (s)-equol producers and non-producers (Figure 6). Because of the antioxidant 
potential performed by the non-polar molecule, due to the penetration more reliable in the 
cell membrane, (s)-equol binds to the estrogenic receptors, downregulating their activity, 
with a potential application in breast and prostate cancer therapy.
 Figure 6. Colonic formation of (s)-equol and O-demethylangolensin from the isoflavone daidzein [12].
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4.1.4. Condensed tannins (proanthocyanidins)
The studies performed using tannins introduced in rat diet concluded that animals with gut micro-
biota enriched with Enterobacteriaceae, Prevotella and B. fragilis had a condensed-tannins diet [20].
Mostly, proanthocyanidins, in their monomeric, oligomeric or polymeric forms, are respon-
sible for the red, blue and purple colour of fruits, of flowers and in a lower manner of leaves, 
showing an important antioxidant role. Although a lot of these compounds enter the colon 
and they are depredated by β-glycosidase by the gut microbiota (especially by Lactobacillus 
casei, Lactobacillus acidophilus and Bifidobacterium lactis), the mechanism that can explain the 
antimicrobial mechanism is correlated with the disintegration of bacterial membrane, with 
the presence of amounts of cytoplasmic material and membrane debris outside the cells. 
Extracts from bilberries and blueberries showed inhibitory effects on the growth of Gram-
positive and Gram-negative bacteria but without a biological effect on yeasts.
4.2. Non-flavonoids
4.2.1. Stilbenes
Resveratrol (3, 5, 4′-trihydroxy-trans-stilbene) has antimicrobial effect against pathogenic 
agents, shown after the administration of this compound to a DSS-induced colitis rat model. 
An important increase in lactobacilli and bifidobacteria, associated with a decrease of entero-
bacteria, was observed after a trial of 20 days [21].
4.2.2. Hydrolysable tannins
This class includes gallotannins and ellagitannins, present in raspberries, cranberries, straw-
berries, grapes and pomegranates. The difference between the two compounds arises at the 
gut microbial hydrolysis level, glucose and gallic acid for the first one and ellagic acid for the 
second one (Figure 7). This is metabolised in the colon to urolithin A and this monohydrox-
 Figure 7. Biosynthetic steps for generation of two hydroxycinnamic acid polymers: ellagitannins and gallotannins [12].
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ylated derivate to urolithin B. Of course, the complexity of the microbiota from the colon is 
responsible for the ellagitannins’ metabolisation.
Pomegranate (Punica granatum) polyphenols have a suppressive activity against influenza 
virus A, due to punicalagin, who blocks the replication process of the virus and inhibits the 
agglutination of red blood cells by the virus. Also, the ellagitannins from this fruit are effec-
tive against S. aureus, Salmonella, Listeria monocytogenes and E. coli [22], and the ellagic acid 
inhibits the biofilm of methicillin-resistant S. aureus [23].
For ellagic acid, it was described an in vitro antimalarial activity, especially P. falciparum 
strains, regardless the levels of chloroquine and mefloquine resistance, influencing the mature 
trophozoite and young schizont stages, respectively, the proteins and nucleic acid synthesis. 
Also, ellagic acid potentiates the activity of current antimalarial drug [24].
4.2.3. Chlorogenic acids
Caffeic acid, ferulic acid and p-coumaric acid are abundant in peaches, plums and coffee seeds.
The main microbial metabolites of caffeic acid are 3-hydroxyphenylpropionic and benzoic 
acids, under the action of E. coli, B. lactis and Lactobacillus gasseri. The metabolites formed by 
ferulic acid in the colon are 3-(4-hydroxy-phenyl)-propionic acid and vanillin.
The role played by the gallic acid is underlined against the synthesis of the biofilms by different 
bacteria (E. coli, Pseudomonas aeruginosa, S. aureus or Listeria monocytogenes), the human rhinovi-
ruses, enteroviruses and herpes simplex virus type 2. Gallic acid from Terminalia nigrovenulosa bark 
has shown strong antifungal activity against Fusarium solani and Meloidogyne incognita [25, 26].
5. Polyphenols-microbiota relationship, at a glance
The interaction between the phenolic compounds as dietary components and gut microbiota 
has gained a lot of attention in the last years, due to their bioavailability and the interest in 
human health. Although we acknowledge about this relationship from data literature, studies 
are lacking, making difficult understanding the exact mechanism of each compound. In vivo 
studies, focused on the ethical and economic issues, are also difficult to translate into in vitro 
conditions. It is clear that dietary polyphenols contribute to the maintenance of the human 
health, especially the gut, by stimulating the growth of beneficial bacteria and the inhibition 
of the pathogen ones, exerting prebiotic-like effects. A better understanding of the interaction 
between dietary polyphenols and gut microbiota through the emerging advances would be 
essential in order to identify genes and micro-organisms involved in polyphenol inactivation 
and conversion and, thus, to elucidate the implications of diet on the modulation of micro-
biota for achieving health benefits.
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